CO6180444A2 - Marcacion con fluor radioactivo - Google Patents

Marcacion con fluor radioactivo

Info

Publication number
CO6180444A2
CO6180444A2 CO09034043A CO09034043A CO6180444A2 CO 6180444 A2 CO6180444 A2 CO 6180444A2 CO 09034043 A CO09034043 A CO 09034043A CO 09034043 A CO09034043 A CO 09034043A CO 6180444 A2 CO6180444 A2 CO 6180444A2
Authority
CO
Colombia
Prior art keywords
group
heteroaryl
aryl
hydrogen
aralkyl
Prior art date
Application number
CO09034043A
Other languages
English (en)
Inventor
Ananth Srinivasan
Lutz Lehmann
Ulrike Rohn
Timo Stellfeld
Simon Ametamey
Ulrich Klar
Aileen Hohne
Linjing Mu
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06076823A external-priority patent/EP1908472A1/en
Priority claimed from EP06076869A external-priority patent/EP1911452A1/en
Priority claimed from EP07090043A external-priority patent/EP1970064A1/en
Priority claimed from EP07090079A external-priority patent/EP1985624A3/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CO6180444A2 publication Critical patent/CO6180444A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13Labelling of peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/14Peptides, e.g. proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0491Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008Peptides; Proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0834Compounds having one or more O-Si linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0896Compounds with a Si-H linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/12Organo silicon halides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086Bombesin; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nuclear Medicine (AREA)
  • Peptides Or Proteins (AREA)

Abstract

1.- Un compuesto que tiene la Fórmula química general IX representa un grupo saliente adecuado para fluoración seleccionado entre el grupo que comprende hidrógeno y OR3, en donde R3 representa hidrógeno, C1-C10 alquilo, C2-C10 alquenilo, C2-C10 alquinilo, arilo, heteroarilo o aralquilo, R1 y R2 se seleccionan, en forma independiente, entre el grupo que comprende hidrógeno, C1-C10 lineal y ramificado, arilo, heteroarilo y aralquilo, -B1- se selecciona entre el grupo que comprende -(CH2]m-D-[CH2]n-A-, en donde n y m son, en forma independiente, cualquier número entero entre 0 y 5, -D- representa una unión, -S-, -O- o -NR4-, en donde R4 representa hidrógeno, C1-C10 alquilo, arilo, heteroarilo o aralquilo, A representa alquilo, arilo sustituido o no sustituido o heteroarilo,E-Z1-Y1- representa una porción seleccionada entre el grupo que comprende EO-C(=O)-, ENR5-C(=O)-, EC(=O)-O-, EC(=O)-NR5-, ENR5-SO2-, ESO2-NR5-, E-O-, E-(S)p-, E-NR5-, ENR6C (=O)-NR7-, ENR6-C(=O)NR7-, ENR6C(=S)-NR7-, ENR6-C (=S)NR7-EO-C(=O)O-, EOC(=O)-O-, EOC(=S)-O-, EO-C(=S)O-, en donde el enlace simple largo que se muestra explícitamente en las Fórmulas precedentes es el enlace entre Z1 y Y1, y en donde las flechas que figuran en las Fórmulas precedentes indican el enlace entre Z1 y Y1, ...
CO09034043A 2006-10-02 2009-04-02 Marcacion con fluor radioactivo CO6180444A2 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06076823A EP1908472A1 (en) 2006-10-02 2006-10-02 Silicon derivatives for PET imaging
EP06076869A EP1911452A1 (en) 2006-10-11 2006-10-11 Silicon-derivates for PET-Imaging
EP07090043A EP1970064A1 (en) 2007-03-12 2007-03-12 Silicon-derivatives for pet-imaging
EP07090079A EP1985624A3 (en) 2007-04-23 2007-04-23 Single step method of radiofluorination of biologically active compounds or biomolecules

Publications (1)

Publication Number Publication Date
CO6180444A2 true CO6180444A2 (es) 2010-07-19

Family

ID=39030886

Family Applications (1)

Application Number Title Priority Date Filing Date
CO09034043A CO6180444A2 (es) 2006-10-02 2009-04-02 Marcacion con fluor radioactivo

Country Status (21)

Country Link
US (1) US20090035215A1 (es)
EP (1) EP2074135A2 (es)
JP (1) JP2010505776A (es)
KR (1) KR20090085599A (es)
AR (1) AR062795A1 (es)
AU (1) AU2007304508A1 (es)
BR (1) BRPI0719956A2 (es)
CA (1) CA2664700A1 (es)
CO (1) CO6180444A2 (es)
CR (1) CR10703A (es)
IL (1) IL197817A0 (es)
MA (1) MA30824B1 (es)
MX (1) MX2009003617A (es)
NO (1) NO20091735L (es)
PA (1) PA8747601A1 (es)
PE (1) PE20081173A1 (es)
SV (1) SV2009003205A (es)
TN (1) TN2009000100A1 (es)
TW (1) TW200820988A (es)
UY (1) UY30596A1 (es)
WO (1) WO2008040441A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011089267A1 (en) * 2010-01-25 2011-07-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Silylated biomolecules
JP5717138B2 (ja) * 2011-05-23 2015-05-13 独立行政法人産業技術総合研究所 タンパク質固定化表面修飾材料
KR102344233B1 (ko) * 2013-06-06 2021-12-27 닛산 가가쿠 가부시키가이샤 액정 배향제, 액정 배향막 및 액정 표시 소자
CA2982269C (en) * 2015-05-26 2023-12-05 The Regents Of The University Of California Heteroaromatic silicon-fluoride-acceptors useful for 18f labeling of molecules and biomolecules, and methods of preparing same
GB2581619A (en) 2017-09-15 2020-08-26 Univ California Inhibition of aminoacylase 3 (AA3) in the treatment of cancer
US20230226228A1 (en) * 2020-05-04 2023-07-20 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for detection of bacterial infection
US20230357100A1 (en) * 2020-09-28 2023-11-09 National Institutes for Quantum Science and Technology Method for producing radioactive labeled substance, device for producing radioactive labeled substance, and method for evaporatively concentrating radioactive metal nuclide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084555A (en) * 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
US5732578A (en) * 1995-02-24 1998-03-31 Hyundai Metal Co., Ltd. Device for maintaining the horizontality of a door lock lever
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
US6639076B1 (en) * 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
EP1192132B1 (en) * 1999-06-14 2005-09-07 Eli Lilly And Company Serine protease inhibitors
WO2002044144A2 (en) * 2000-11-30 2002-06-06 Advanced Research And Technology Institute, Inc. Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
CA2516685A1 (en) * 2003-02-20 2004-09-02 University Of South Florida Peptidomimetic inhibitors of stat3 activity and their medical uses
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
US8114381B2 (en) * 2004-02-13 2012-02-14 The University Of British Columbia Radiolabeled compounds and compositions, their precursors and methods for their production
US20080029548A1 (en) * 2006-05-05 2008-02-07 Ann De Wree Fabric treatment dispensing package

Also Published As

Publication number Publication date
MA30824B1 (fr) 2009-10-01
PE20081173A1 (es) 2008-11-06
WO2008040441A3 (en) 2009-01-08
WO2008040441A2 (en) 2008-04-10
US20090035215A1 (en) 2009-02-05
JP2010505776A (ja) 2010-02-25
BRPI0719956A2 (pt) 2014-04-29
AU2007304508A8 (en) 2009-05-14
MX2009003617A (es) 2009-04-22
PA8747601A1 (es) 2009-08-26
UY30596A1 (es) 2008-05-02
CA2664700A1 (en) 2008-04-10
EP2074135A2 (en) 2009-07-01
IL197817A0 (en) 2009-12-24
KR20090085599A (ko) 2009-08-07
CR10703A (es) 2009-06-25
AU2007304508A1 (en) 2008-04-10
TW200820988A (en) 2008-05-16
TN2009000100A1 (en) 2010-08-19
SV2009003205A (es) 2009-10-19
AR062795A1 (es) 2008-12-03
NO20091735L (no) 2009-06-30

Similar Documents

Publication Publication Date Title
CO6180444A2 (es) Marcacion con fluor radioactivo
AR050254A1 (es) Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas
GT200600306A (es) Inhibidores de glutamato agrecanasa
BRPI0516735B8 (pt) métodos para produção de (r)-2-acetamido-n-benzil-3-metoxipropionamida (lacosamida) e de uma formulação farmacêutica, e uso de (r)-n-benzil-2-nboc-amino-3-metoxipropionamida (c-937)
CR10499A (es) Profarmaco de compuesto de cinamida
FR2868467B1 (fr) Carter de turbine a crochets refractaires obtenu par procede mdp
RS54047B1 (en) PROCEDURE FOR OBTAINING 4-OXOCHINOLINE COMPOUNDS
ATE519737T1 (de) Organische verbindungen
FR2863053B1 (fr) Nouvelles sondes hybrides a luminescence exaltee
HN2009000113A (es) Derivados novedosos de aminopiridina que tiene accion inhibidora selectiva sobre aurora a
FR2921572B1 (fr) Dispositif de conformation circulaire d'une piece de revolution, notamment un carter d'echappement d'une turbomachine
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
BRPI0512310A (pt) compostos quìmicos
UY30009A1 (es) Compuestos benzoilpirazol y herbicidas que los contienen
RU2010131168A (ru) Сульфенамид, ускоритель вулканизации каучука, содержащий сульфенамид и способ получения ускорителя вулканизации
AR073201A1 (es) Compuestos de amida y su uso.
ITMI20032327A1 (it) Bruciatore a gas a basse emissioni inquinanti.
EA200702290A1 (ru) Мотилидные соединения
GT200300183A (es) Nuevos agonistas ppar-alfa y ppar-gamma
AR072801A1 (es) Aplicacion de explosivo de alta temperatura para uso en profundidad de pozo
RU2008151868A (ru) Мономер для поликонденсации
DE602007008588D1 (de) Verfahren zur herstellung von alkylencarbonat
EA200301292A1 (ru) Способ синтеза тропенола для его получения в промышленном масштабе
CR9692A (es) Derivados de 2-oxo-imidazol sustituidos con dihidroxialquilo en n
NO20052680D0 (no) Forbedringsmiddel inneholdende brennstoff.

Legal Events

Date Code Title Description
FA Application withdrawn